Mesothelioma Clinical Trials at Dana-Farber/Harvard Cancer Center

Clinical Trials at Dana-Farber/Harvard Cancer Center

Phase II Trial of MTA Administered Intravenously Every 21 Days in Patients With Malignant Pleural Mesothelioma (offered at Dana-Farber Cancer Institute, Brigham & Women's Hospital and Massachusetts General Hospital)

Phase I Trial of Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin and Intravenous Sodium Thiosulphate in the Multimodality Treatment of Malignant Pleural Mesothelioma (offered at Dana-Farber Cancer Institute and Brigham & Women's Hospital)

Phase I Trial of Extrapleural Pneumonectomy Followed by Intrathoracic/Intraperitoneal Heated Cisplatin and Intravenous Sodium Thiosulfate in the Multimodality Treatment of Malignant Pleural Mesothelioma (offered at Dana-Farber Cancer Institute and Brigham & Women's Hospital)

Phase II Study of Capecitabine in Patients With Malignant Mesothelioma

Back to Comprehensive Cancer Centers

To receive a FREE Mesothelioma Web information packet** or to make a request, please fill out the following form :

**For a FREE information packet including treatments, clinical trials, and specialists, please complete the form above or call a Mesothelioma Web coordinator at 1-877-367-6376.

News

Resources

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376